General Announcement::Company Statement

Issuer & Securities

Issuer/ Manager
BIOCON BIOLOGICS GLOBAL PLC
Securities
BIOCONBIO US$800M6.67%N291009A - US090978AA56 - RJUB
BIOCONBIO US$800M6.67%N291009R - USG11185AA61 - KSEB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
04-Sep-2025 22:06:00
Status
New
Announcement Sub Title
Company Statement
Announcement Reference
SG250904OTHR52US
Submitted By (Co./ Ind. Name)
Biocon Biologics Limited / Akhilesh Nand
Designation
Company Secretary
Effective Date and Time of the event
04/09/2025 19:35:00
Description (Please provide a detailed description of the event in the box below)
U.S. FDA Completes Inspection at Biocon Biologics Facility at Biocon Campus, Bengaluru, India

Attachments

BBL_SGX_USFDA_04092025.pdf
Total size =248K